Develops vaccines for infectious diseases.
Mar 2025Revenue $6.33K/yrExpenses $6.17M/yr
No trendCash runway ≈ 10 months from Mar 2025
Figures by year
When will Virax Biolabs Group be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Mar 2025, revenue was $6.33K and expenses $6.17M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2025 | $6.33K | $6.17M | −$6.16M |
| Mar 2024 | $156K | $6.65M | −$6.50M |
| Mar 2023 | $8.56K | $5.74M | −$5.73M |
| Mar 2022 | $0.00 | $1.73M | −$1.73M |
| Mar 2021 | $124K | $768K | −$645K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.